See the DrugPatentWatch profile for daxxify
What patent covers Revance’s “Daxxify” (daxibotulinumtoxinA)?
Public patent data for a specific “Daxxify” (daxibotulinumtoxinA) claim depends on the exact product name, jurisdiction (US vs. EP vs. PCT family members), and which formulation/method/use claim you mean. With only the question provided, I can’t identify the exact patent number(s) you’re looking for.
If you share either:
- a patent number you’ve seen, or
- the country/region (US, EP, UK, etc.), or
- a link/screenshot to the page where you saw “Daxxify,”
…I can pinpoint the relevant patent(s) and explain what each one covers.
How long will Daxxify patents last (and when could generics/biosimilars enter)?
“Daxxify” is a prescription biologic/drug product, and competitive entry timing is driven by more than just the base patent term. The actual window to market competitors can depend on:
- when the underlying composition, formulation, or method-of-use patents expire,
- whether any extensions apply (e.g., in the US),
- exclusivity tied to the first approval/regulatory pathway,
- and litigation outcomes (common in this space).
To compute a realistic timeline, I need the specific patent numbers (or at least the family) you want tracked.
Are there multiple patents for Daxxify, or one core patent?
Drug product portfolios usually include many patents across different layers, such as:
- active ingredient / composition,
- manufacturing process,
- formulation and delivery,
- clinical use or dosing regimens,
- and sometimes related improvements.
So “the Daxxify patent” could refer to a family of related patents rather than a single document. If you provide the patent family or country, I can map what’s typically included.
Why do people track Daxxify patent expiration?
Because Revance’s competitors and contract manufacturers use patent status to gauge whether:
- an at-risk generic/biosimilar could file,
- a challenge would be viable,
- or a settlement/authorized entry is likely.
This also affects R&D planning and investor expectations.
What I need from you to answer precisely
Please paste one of the following:
1) The patent number you mean (e.g., USxxxxxxx), or
2) The jurisdiction (US or EP) and any patent family name/number you saw, or
3) The URL or text from the source page mentioning the “Daxxify” patent.
Then I can give a targeted answer: which patent(s) cover Daxxify, what the claims protect, and the likely expiration/entry timing tied to those documents.